By: Barbara Boughton 02 November 2010 (San Francisco, California) — A new study from an inner-city hospital in Atlanta, Georgia, of 348 patients with a diagnosis of atypical squamous cells of undetermined significance (ASC-US) confirms that high-risk human papillomavirus (HPV) assay testing is essential for pinpointing patients with high-grade dysplasia who need follow-up treatment, according […]
Kenya: Early Tests Can Reduce Cervical Cancer Deaths
AllAfrica.com
Gatonye Gathura
30 December 2010
Nairobi — As the year ends tonight, almost 2,000 women will have died from cervical cancer in the last 12 months.
Cervical cancer, mainly caused by a sexually transmitted virus, attacks some 2,454 women annually but only about 700 survive.
While breast cancer leads in newly diagnosed cases annually, it has higher survival rates compared to cancer of the cervix, a year-end review reveals.
Grant launches cervical cancer-free Indiana initiative
PHYSORG.com December 2nd, 2010 Indiana will join a multi-state program focused on cervical cancer prevention thanks to an unrestricted gift from GlaxoSmithKline Pharmaceuticals to the Indiana University School of Medicine, in partnership with the Kristen Forbes EVE Foundation. Cervical Cancer-Free America (CCFA) is an initiative designed to raise awareness, increase screenings for cervical cancer and […]
HPV test is next step for women
Mirror United Kingdom By Miriam Stoppard 22/11/2010 We’ve made great inroads in the fight against cervical cancer. Before the cervical screening programme was introduced in 1988, the death rate from the disease had tripled over 20 years. Now regular smear tests save an estimated 5,000 lives a year, according to the charity Cancer Research UK. […]
Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China
The Lancet Oncology, Early Online Publication, 12 November 2010 doi:10.1016/S1470-2045(10)70256-4 Fang-Hui Zhao MD a *, Margaret Jane Lin BS b *, Feng Chen BSc a, Shang-Ying Hu MD a, Rong Zhang MD a, Jerome L Belinson MD c, Prof John W Sellors MD d, Silvia Franceschi MD e, Prof You-Lin Qiao PhD a , Philip […]
- « Previous Page
- 1
- …
- 20
- 21
- 22
- 23
- 24
- …
- 27
- Next Page »
